shovel.report

Icon for linkedin.enzyme.financelinkedin.enzyme.finance

DNS Records

A104.22.50.150
A104.22.51.150
A172.67.15.83
AAAA2606:4700:10::6816:3296
AAAA2606:4700:10::6816:3396
AAAA2606:4700:10::ac43:f53

Affiliations

Subdomains

JSON+LD

{
  "@context": "http://schema.org",
  "@graph": [
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-06-06T15:30:09.838Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_were-thrilled-to-share-that-enzyme-has-won-activity-7336776422633410563-SifQ",
      "text": "We’re thrilled to share that Enzyme has won Blockchain Technology of the Year Award at the Hedgeweek® Global Digital Assets Awards 2025. 🏆\n\nIt’s an honor to be recognized for the work we’re doing to build real infrastructure for tokenized finance, and to stand alongside other outstanding category nominees like R3, Talos, Triangle Digital, and SWIAT.\n\nThanks to HedgeWeek for hosting a fantastic summit in London, and to our founder Mona El Isa, who was there to receive the award. 🤝",
      "url": "https://www.linkedin.com/posts/enzymefinance_were-thrilled-to-share-that-enzyme-has-won-activity-7336776422633410563-SifQ"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-06-05T14:06:37.771Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_according-toa-recent-report-from-binance-activity-7336393012643557376-UCxx",
      "text": "According to a recent report from Binance, the RWA tokenization market has experienced a remarkable 260% growth in the first half of 2025, reaching a valuation of $23 billion. 📈\n\nThis surge is largely attributed to increasing regulatory clarity in the industry, which has encouraged firms to embrace regulated crypto frameworks.\n\nAt Enzyme, we’re witnessing this momentum firsthand. Our solutions enable users to manage tokenized assets within customizable vaults, facilitating strategies that leverage RWAs effectively.\n\nExplore how Enzyme can support your RWA strategies: https://lnkd.in/dVE8YEmB",
      "url": "https://www.linkedin.com/posts/enzymefinance_according-toa-recent-report-from-binance-activity-7336393012643557376-UCxx"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-06-04T13:43:45.391Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_rwas-are-the-bridge-between-traditional-capital-activity-7336024868565520386-ZCTv",
      "text": "RWAs are the bridge between traditional capital and DeFi strategy. Vaults are how you cross it.\n\nOn Enzyme, RWAs can be deposited into customizable vaults, unlocking new ways to manage, monitor, and interact with tokenized capital.\n\nWith Enzyme, you can:\n- Build and distribute financial instruments with RWA exposure without the operational overhead.\n- Pool RWAs within a dedicated liquidity vehicle or raise capital for RWA strategies with built-in incentive mechanisms.\n- Integrate tokenized Treasury Bills, stocks, bonds, real estate, and more into your fund strategy.\n\nEnzyme gives financial builders the tools to move from tokenization to activation, turning static representations into live, operational components of a fund or strategy.\n\nLearn more: https://lnkd.in/dVE8YEmB",
      "url": "https://www.linkedin.com/posts/enzymefinance_rwas-are-the-bridge-between-traditional-capital-activity-7336024868565520386-ZCTv"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-06-03T15:30:17.367Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_how-rwas-are-tokenized-activity-7335689290623991808-v9FX",
      "text": "How do real-world assets go onchain? Here’s the step-by-step breakdown 👇",
      "url": "https://www.linkedin.com/posts/enzymefinance_how-rwas-are-tokenized-activity-7335689290623991808-v9FX"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-05-31T12:06:25.653Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_this-week-the-secs-division-of-corporation-activity-7334550823500169217-yDWP",
      "text": "This week, The SEC’s Division of Corporation Finance clarified that certain proof-of-stake activities, when structured appropriately, do not constitute securities transactions.\n\nIt’s a meaningful move. Staking is a foundational pillar of DeFi and increasingly, a core component in modern portfolio construction. As institutional interest grows in tokenized strategies, staking exposure is becoming a part of a balanced, on-chain investment design.\n\nWe provide the infrastructure for staking strategies with Enzyme​.Blue, which supports integrations with providers like Kiln, and more than 30 protocols. Now with SEC’s statement, more clarity means more confidence. More confidence means better strategies.\n\nIf you’re a staking protocol, explore the Enzyme solutions to grow your business → https://lnkd.in/dJVd3iRD",
      "url": "https://www.linkedin.com/posts/enzymefinance_this-week-the-secs-division-of-corporation-activity-7334550823500169217-yDWP"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-05-30T16:41:25.475Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_glad-to-be-a-part-of-gorilla-funds-journey-activity-7334257640870428674-aV-M",
      "text": "Glad to be a part of Gorilla Funds' journey 🤝",
      "url": "https://www.linkedin.com/posts/enzymefinance_glad-to-be-a-part-of-gorilla-funds-journey-activity-7334257640870428674-aV-M"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-05-29T14:26:13.512Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_stand-out-with-boosted-staking-activity-activity-7333861229016383490-LtsJ",
      "text": "Stand out with boosted staking activity.\n\nYou are a driving force behind decentralization, ensuring network resilience and security. Enzyme enables you to execute your mission with greater efficiency, attracting more stakers, unlocking additional yield, and driving liquidity where it matters.\n\nWith Enzyme Vaults, you can design complementary, yield-generating products specifically for stakers. Whether delegated or not, automated or not, your strategy is supported with seamless distribution and effortless 1-click experiences for users.\n\nEnzyme also simplifies liquidity provision for LSTs and LRTs. Create incentivized staking pools that offer LP fees and other benefits while orchestrating liquidity across multiple protocols, all from a single place.\n\nWhy choose Enzyme?\n- Unlimited options for bespoke tokenized finance strategies\n- Rewards and benefits including LP fees, point computation, and extra yield\n- Seamless experiences via white-label integration\n\nFrom advisory and development to strategy curation, Enzyme supports you every step of the way.\n\n🧬 Learn more → https://lnkd.in/dJVd3iRD",
      "url": "https://www.linkedin.com/posts/enzymefinance_stand-out-with-boosted-staking-activity-activity-7333861229016383490-LtsJ"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-05-27T15:03:21.596Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_your-next-tokenized-fund-strategy-doesnt-activity-7333145798538321923-NRvM",
      "text": "Your next tokenized fund strategy doesn’t need middlemen, months of dev work, or 10 vendors.\n\nWhether you’re managing tokenized funds, Enzyme gives you the infrastructure to launch, operate, and scale onchain fund strategies with built-in flexibility across deployment, custody, and execution.\n\n→ With Enzyme​.Blue, you can create and manage natively tokenized products directly through a secure all-in one environment, without external integrations or wallet setup.\n→ With Enzyme.Onyx, you can deploy Enzyme Vaults on top of your existing wallet setup, enabling you to transform it into a tokenized solution.\n→ With Enzyme.Myso, you can integrate covered calls and cash-secured puts directly into your fund strategy to add yield and structure.\n\nManage fund logic, and control ownership & activity while accessing performance analytics, protocol integrations, and strategy automation.\n\nLearn more: https://lnkd.in/dYcYvBB6",
      "url": "https://www.linkedin.com/posts/enzymefinance_your-next-tokenized-fund-strategy-doesnt-activity-7333145798538321923-NRvM"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-05-26T15:04:51.961Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_enzymemyso-v3-just-passed-16m-in-total-activity-7332783789712011267-Hm3Z",
      "text": "Enzyme.Myso v3 just passed $16M in total notional volume. 📈\n\nLaunched earlier this year, the protocol is powering covered calls and cash-secured puts at scale, most recently a $1.2M call on $AAVE.\n\nIt’ll only get bigger from here. Learn more → https://lnkd.in/dDC9C3c8",
      "url": "https://www.linkedin.com/posts/enzymefinance_enzymemyso-v3-just-passed-16m-in-total-activity-7332783789712011267-Hm3Z"
    },
    {
      "@context": "http://schema.org",
      "@type": "Organization",
      "name": "Enzyme",
      "url": "https://www.linkedin.com/company/enzymefinance",
      "description": "Enzyme provides industry leaders with a comprehensive infrastructure to manage on-chain assets efficiently, optimize operational processes, and develop innovative financial strategies tailored to their unique goals and challenges",
      "numberOfEmployees": {
        "value": 15,
        "@type": "QuantitativeValue"
      },
      "logo": {
        "contentUrl": "https://media.licdn.com/dms/image/v2/D4E0BAQHl8xHN_v5A_w/company-logo_200_200/B4EZY0LJThHUAQ-/0/1744632059479/enzymefinance_logo?e=2147483647&v=beta&t=OA2uR1-rGgAeJCbBd7HHeYb1FYQaRPr5jc8tpjhNBC0",
        "description": "Enzyme",
        "@type": "ImageObject"
      },
      "slogan": "The global infrastructure for tokenized finance.",
      "sameAs": "https://enzyme.finance"
    }
  ]
}
© 2025. I hope you have a nice day.